| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.0M | +5268.8% |
| R&D Expense | $8.4M | +45.6% |
| SG&A Expense | $8.5M | +38.5% |
| Operating Income | -$15.8M | -33.7% |
| Pre-tax Income | -$15.8M | -112.4% |
| Income Tax | $218K | — |
| Net Income | -$16.0M | -115.3% |
| EPS (Basic) | -$3.95 | +65.2% |
| EPS (Diluted) | -$3.95 | +65.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | +3325.9% |
| Current Assets | $14.3M | +577.2% |
| Total Assets | $14.9M | +437.1% |
| Current Liabilities | $4.1M | +27.6% |
| Total Liabilities | $4.1M | +25.8% |
| Stockholders' Equity | $10.8M | +2320.9% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.8M | -49.0% |
| Investing Cash Flow | -$12K | +0.0% |
| Financing Cash Flow | $26.0M | +301.0% |